Healthcare provider profile · identity verified

Shalini Niranjan

Family Practice · TOLEDO, OH · NPI 1477864262

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	621	153
Lisinopril	Lisinopril	452	106
Losartan Potassium	Losartan Potassium	380	85
Amlodipine Besylate	Amlodipine Besylate	359	93
Levothyroxine Sodium	Levothyroxine Sodium	345	76
Omeprazole	Omeprazole	280	68
Metformin Hcl	Metformin Hcl	251	62
Hydrochlorothiazide	Hydrochlorothiazide	247	64
Famotidine	Famotidine	241	56
Sertraline Hcl	Sertraline Hcl	202	46
Gabapentin	Gabapentin	188	41
Trazodone Hcl	Trazodone Hcl	185	45
Metoprolol Succinate	Metoprolol Succinate	173	43
Pravastatin Sodium	Pravastatin Sodium	170	39
Furosemide	Furosemide	155	37
Fluticasone Propionate	Fluticasone Propionate	151	53
Potassium Chloride	Potassium Chloride	150	41
Rosuvastatin Calcium	Rosuvastatin Calcium	138	44
Citalopram Hbr	Citalopram Hydrobromide	136	23
Buspirone Hcl	Buspirone Hcl	131	27
Pantoprazole Sodium	Pantoprazole Sodium	123	33
Montelukast Sodium	Montelukast Sodium	122	27
Bupropion Xl	Bupropion Hcl	105	22
Metoprolol Tartrate	Metoprolol Tartrate	105	27
Allopurinol	Allopurinol	98	25
Fluoxetine Hcl	Fluoxetine Hcl	94	19
Mounjaro	Tirzepatide	87	13
Prednisone	Prednisone	86	76
Oxybutynin Chloride Er	Oxybutynin Chloride	84	20
Carvedilol	Carvedilol	80	20
Atenolol	Atenolol	67	17
Januvia	Sitagliptin Phosphate	66	14
Tramadol Hcl	Tramadol Hcl	65	22
Albuterol Sulfate Hfa	Albuterol Sulfate	61	24
Meloxicam	Meloxicam	60	16
Synthroid	Levothyroxine Sodium	56	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	55	27
Tizanidine Hcl	Tizanidine Hcl	55	27
Eliquis	Apixaban	52	15
Simvastatin	Simvastatin	52	17
Clopidogrel	Clopidogrel Bisulfate	51	11
Alendronate Sodium	Alendronate Sodium	49	12
Spironolactone	Spironolactone	49	14
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	44	suppressed
Jardiance	Empagliflozin	42	12
Tamsulosin Hcl	Tamsulosin Hcl	42	11
Glipizide	Glipizide	40	12
Mirtazapine	Mirtazapine	39	suppressed
Ezetimibe	Ezetimibe	37	11
Fenofibrate	Fenofibrate	36	suppressed
Metformin Hcl Er	Metformin Hcl	36	suppressed
Ozempic	Semaglutide	36	suppressed
Meclizine Hcl	Meclizine Hcl	35	18
Warfarin Sodium	Warfarin Sodium	34	suppressed
Alprazolam	Alprazolam	33	suppressed
Arnuity Ellipta	Fluticasone Furoate	33	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	33	suppressed
Azelastine Hcl	Azelastine Hcl	32	13
Escitalopram Oxalate	Escitalopram Oxalate	32	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	13
Memantine Hcl	Memantine Hcl	31	suppressed
Breo Ellipta	Fluticasone/Vilanterol	30	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	suppressed
Nystatin	Nystatin	29	13
Farxiga	Dapagliflozin Propanediol	27	suppressed
Ondansetron Odt	Ondansetron	27	13
Azithromycin	Azithromycin	26	26
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Duloxetine Hcl	Duloxetine Hcl	25	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	16
Valacyclovir	Valacyclovir Hcl	22	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	15
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Lorazepam	Lorazepam	20	suppressed
Risperidone	Risperidone	20	suppressed
Cephalexin	Cephalexin	19	15
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Amoxicillin	Amoxicillin	17	13
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	17	suppressed
Novolog Flexpen	Insulin Aspart	17	suppressed
Topiramate	Topiramate	17	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Midodrine Hcl	Midodrine Hcl	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	14
Glimepiride	Glimepiride	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	15	suppressed
Irbesartan	Irbesartan	14	suppressed
Klor-Con M20	Potassium Chloride	14	suppressed
Metronidazole	Metronidazole	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Cartia Xt	Diltiazem Hcl	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	13
Valsartan	Valsartan	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Prolia	Denosumab	12	suppressed
Tiotropium Bromide	Tiotropium Bromide	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Diclofenac Sodium Er	Diclofenac Sodium	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Naproxen	Naproxen	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error